BackImmage Biotherapeutics Overview

Immage Biotherapeutics Net Tangible Assets

Immage Biotherapeutics's net tangible assets is $22K.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$22343.00
↓ 92.56% YoYΔ $-277800.00 vs prior year quarter

Peer trimmed avg / median

Loading

Immage Biotherapeutics Net Tangible Assets History

Loading

Immage Biotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

Immage Biotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immage Biotherapeutics (IMMG) FAQ

As of the most recent data (February 2017), IMMG shows a net tangible assets of $22K. That compares with $300K in the prior-year period — down 92.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMMG's net tangible assets is now $22K (was $300K) — a 92.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Immage Biotherapeutics is outperforming or lagging.

Tracking IMMG's net tangible assets over time shows whether Immage Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $22K That compares with $300K in the prior-year period — down 92.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Immage Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $22K) with ownership activity and broader fundamentals.